Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
1. 请及时下载文件确认是否正确, 系统将在 2025-07-18 11:58:02 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1001/jamaoncol.2020.7932
文献链接: https://jamanetwork.com/journals/jamaoncology/fullarticle/2775599
其他信息:
出版社: American Medical Association (AMA)
作者: Hope S. Rugo; Seock-Ah Im; Fatima Cardoso; Javier Cortés; Giuseppe Curigliano; Antonino Musolino; Mark D. Pegram; Gail S. Wright; Cristina Saura; Santiago Escrivá-de-Romaní; Michelino De Laurentiis; Christelle Levy; Ursa Brown-Glaberman; Jean-Marc Ferrero; Maaike de Boer; Sung-Bae Kim; Katarína Petráková; Denise A. Yardley; Orit Freedman; Erik H. Jakobsen; Bella Kaufman; Rinat Yerushalmi; Peter A. Fasching; Jeffrey L. Nordstrom; Ezio Bonvini; Scott Koenig; Sutton Edlich; Shengyan Hong; Edwin P. Rock; William J. Gradishar; undefined undefined